Recent decades have witnessed unprecedented scientific growth driven by the convergence of clinical medicine, life sciences, ...

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes ...

Multidimensional analyses demonstrate that repeated DeltEx DRI dosing preserves immune function, drives tumor microenvironment remodeling, and ...

Owkin has signed a new multi-year agreement with AstraZeneca centered around K Pro, Owkin’s agentic AI platform designed for pharmaceutical research and strategic decision-making. Under the three-year ...

Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...

Using spatial transcriptomics and single-cell sequencing, researchers mapped out gene expression patterns in the neurons of ...

In 2026, CRISPR therapies, precision medicine, and AI-driven drug discovery are transitioning from clinical trials to real-world patient care and market adoption. Regulatory innovations, capital ...

Time to Invest? 10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue ...

In this session you will learn how spatial transcriptomics with single-cell resolution enable detailed cellular mapping of ...

Aerobic glycolysis dominates lesion bioenergetics, with lactate promoting histone lactylation, M2 macrophage polarization, ...

Advaita Bio today announced the launch of iSCanGuide, a cloud-based platform engineered to transform large-scale single-cell and spatial transcriptomics datasets into biologically meaningful results.

GPU-Accelerated Platform Unifies Fragmented Workflows, Turning Weeks of Analysis into MinutesANN ARBOR, Mich., May 7, 2026 /PRNewswire/ -- Advaita Bio today announced the launch of iSCanGuide ...